ROSIGLITAZONE TREATMENT DOES NOT DECREASE AMYLOID DEPOSITION IN TRANSPLANTED ISLETS FROM TRANSGENIC MICE EXPRESSING HUMAN ISLET AMYLOID POLYPEPTIDE

In human islet transplantation, insulin independence decreases over time. We previously showed that amyloid deposition following transplantation of islets from human islet amyloid polypeptide (hIAPP) transgenic mice resulted in β-cell loss, and that rosiglitazone treatment decreased islet amyloid de...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Udayasankar, Jayalakshmi, Zraika, Sakeneh, Aston-Mourney, Kathryn, Subramanian, Shoba L, Brooks-Worrell, Barbara M, Taborsky, Gerald J, Hull, Rebecca L
Format: Artigo
Langue:Inglês
Publié: 2012
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3602214/
https://ncbi.nlm.nih.gov/pubmed/23267797
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.transproceed.2012.05.079
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires